FTC Challenges Branded Drug Patents, Aiming to Lower Prices for Type 2 Diabetes and Asthma Medications
FTC Expands Effort to Challenge Bogus Drug Patents – News Website FTC Expands Effort to Challenge Bogus Drug Patents The Federal Trade Commission (FTC) has intensified its campaign against fraudulent drug patents in a bid to address rising prescription drug costs. Pharma companies have long utilized multiple patents to shield their top-selling medications, blocking competition … Read more